Trials / Completed
CompletedNCT00185159
Olmesartan Medoxomil in Diabetes Mellitus
Randomized Olmesartan and Diabetes Microalbuminuria Prevention Study (ROADMAP)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 4,449 (actual)
- Sponsor
- Sankyo Pharma Gmbh · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a study in diabetic patients with at least one additional cardiovascular risk factor and normoalbuminuria prior to randomization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olmesartan medoxomil | tablets |
| DRUG | Placebo Tablets | Tablets |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2005-09-16
- Last updated
- 2010-01-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00185159. Inclusion in this directory is not an endorsement.